Akihiro Hosoi Selected Research

Akihiro Hosoi Research Topics

Disease

21	Neoplasms (Cancer) 04/2023 - 05/2008
4	Experimental Melanoma 01/2018 - 04/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 05/2018
2	Lung Neoplasms (Lung Cancer) 01/2017 - 03/2016
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Necrosis 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 07/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Adenocarcinoma 01/2017
1	Testicular Neoplasms (Testicular Cancer) 10/2015
1	Infections 05/2008

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2017
4	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2018
4	AntigensIBA 01/2017 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2015
2	Programmed Cell Death 1 ReceptorIBA 10/2020 - 01/2020
2	VaccinesIBA 01/2018 - 03/2016
2	AntibodiesIBA 01/2018 - 10/2015
2	Messenger RNA (mRNA)IBA 02/2017 - 06/2008
2	Cytostatic AgentsIBA 03/2015 - 01/2015
2	Indicators and Reagents (Reagents)IBA 03/2015 - 01/2015
2	InterferonsIBA 03/2015 - 07/2012
1	taxaneIBA 01/2021
1	PlatinumIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Small Cytoplasmic RNAIBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	Everolimus FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	temsirolimus FDA Link 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Type 4 Fibroblast Growth Factor ReceptorIBA 05/2018
1	Protein Subunit VaccinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	CytokinesIBA 01/2018
1	CarbonIBA 07/2017
1	CalreticulinIBA 07/2017
1	Complementary DNA (cDNA)IBA 02/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 10/2015
1	AutoantibodiesIBA 10/2015
1	EpitopesIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015
1	Neutralizing AntibodiesIBA 01/2015
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2015
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2014
1	Monoclonal AntibodiesIBA 07/2012
1	Peptides (Polypeptides)IBA 05/2008

Therapy/Procedure

11	Immunotherapy 04/2023 - 01/2009
11	Therapeutics 01/2021 - 01/2009
1	Drug Therapy (Chemotherapy) 01/2021
1	Transplantation 05/2018
1	Heavy Ion Radiotherapy 07/2017
1	Radiotherapy 07/2017
1	Intravenous Injections 08/2015